Brain Computer Interface Market

Brain Computer Interface Market Size, Share & Trends by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029

Report Code: HIT 9020 May, 2024, by marketsandmarkets.com

Brain Computer Interface Market Size, Share & Trends

The size of global brain computer interface market in terms of revenue was estimated to be worth $262 million in 2024 and is poised to reach $506 million by 2029, growing at a CAGR of 14.1% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The growth of the brain computer interface market is mainly driven by the increasing demand for non-invasive and wearable BCI devices and rising Investments in research and development.

Brain Computer Interface Market Trends

Brain Computer Interface Market

To know about the assumptions considered for the study, Request for Free Sample Report

Brain Computer Interface Market

Brain computer interface industry Dynamics

DRIVER: Growing need to minimize medication errors

The prevalence of various neurological disorders, encompassing stroke, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). These conditions affect millions of people globally, limiting mobility, communication, and independence. This escalation is primarily linked to the expanding elderly population, with projections indicating that over 20% of the global populace will be above 65 by 2050. Forecasts from the American Medical Association (AMA) suggest that by 2030, approximately 60% of individuals in this age bracket will contend with multiple chronic conditions.

The growing incidence of these neurological disorders underscores the critical need for BCI solutions. BCIs offer a novel approach to address these unmet needs. They can help individuals with neurological disorders regain control of prosthetic limbs, operate assistive technologies, and even communicate through brain signals. As BCI technology advances and clinical applications become more widespread, the market is poised for continued growth in the years to come.

RESTRAINT: High cost of brain computer interface systems

The high initial investment required for acquiring and implementing BCI technology poses a significant barrier to entry for many potential users. This cost factor not only affects individual consumers but also dissuades healthcare facilities, research institutions, and other organizations from adopting BCI solutions on a larger scale. The high cost of BCI systems limits accessibility to BCI technology, particularly for individuals and organizations with budget constraints or limited financial resources.

Moreover, the total cost of ownership for BCI systems extends beyond the initial purchase price and includes expenses related to installation, training, maintenance, and ongoing support. These additional costs further compound the financial burden associated with adopting BCI solutions. As a result, many potential users may hesitate to invest in BCI technology, leading to slower market growth and adoption rates than anticipated.

OPPORTUNITY: Growth opportunities in emerging markets

The burgeoning economies of emerging markets present lucrative prospects for players within the brain computer interface sector, primarily fuelled by the significant rise in demand for advanced healthcare solutions, including BCI systems, to address the growing burden of neurological disorders and disabilities. Notably, nations like Brazil, Russia, India, China, and South Africa have emerged as some of the world's fastest-growing economies, poised to collectively contribute to a third of the global healthcare expenditure by 2022, as per the World Economic Forum.

Emerging markets present an opportunity to develop low-cost and scalable BCI solutions tailored to the specific needs and budgetary constraints of these regions. Moreover, the regulatory landscape in developing nations tends to be less stringent, with lower data requirements. Particularly in the Asia-Pacific region, regulatory policies are perceived as more adaptable and conducive to business, garnering favor among market players. Consequently, the market players are increasingly focusing on expanding their presence and operations in these regions to capitalize on the burgeoning opportunities.

CHALLENGE: Shortage of trained medical professionals

Trained medical personnel are required to operate BCI systems effectively for rehabilitation. The positioning of electrodes on the scalp and the insertion of muscular needles require accuracy and must be performed only by highly-trained personnel. The presence of highly skilled medical personnel and staff is, therefore, vital for the effective use of BCI systems.

Skilled medical personnel are currently in short supply worldwide, with the WHO estimating a shortage of 4.3 million physicians, nurses, and other health professionals. In the US, the Association of American Medical Colleges (AAMC) predicts a shortfall of up to 124,000 physicians by 2034 due to factors like population growth and aging. The Canadian Nurses Association predicted that Canada was expected to lack around 60,000 nurses by 2022. Additionally, there's a global shortage of neurodiagnostic technologists, prompting hospitals to train other allied health professionals. This poses a significant obstacle to the expansion of the global brain-computer interface market.

Brain computer interface industry Ecosystem

The Brain computer interface market ecosystem comprises entities responsible for delivering these solutions to end users.

The ecosystem comprises of manufacturers of brain computer interface solutions, research institutions, investors & venture capital firms, healthcare providers, healthcare professionals, patient and caregivers, and governments and regulatory bodies.

Brain Computer Interface Market Ecosystem

Hardware is the largest component of the brain computer interface industry in 2023, by component.

Based on component, the brain computer interface market is segmented into hardware and software. The hardware segment accounted for the largest share of the brain computer interface market in 2023. Hardware forming the foundational backbone of BCI functionality, providing essential components like EEG headsets, neural implants, and sensors vital for capturing and processing neural signals and significant investments will fuel the demand for BCI hardwares.

The non-invasive brain computer interface segment accounted for the largest share of the brain computer interface industry, by product type.

Based on product type, the brain computer interface market is segmented into non-invasive brain computer interface, partially invasive brain computer interface, and invasive brain computer interface. Among these, non-invasive brain computer interface segment accounted for the largest share of the brain computer interface market in 2023, attributing to the rising prevalence of neurological diseases, and reduced risks associated with surgical implants.

The electroencephalography (EEG) segment accounted for the largest share in the brain computer interface industry , by technology.

Based on technology, the brain computer interface market is segmented into Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Magnetoencephalography (MEG), Electrocorticography (ECoG), and Functional Near-Infrared Spectroscopy (fNIRS). The electroencephalography (EEG) segment accounted for the largest share of the market in 2023, attributing to the growing R&D in the field of cerebral and spinal disorders, and significant adoption of EEG among researchers.

North America accounted for the largest share of the brain computer interface industry in 2023.

Brain Computer Interface Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Based on the region, the brain computer interface market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the brain computer interface market in 2023. This is due to the growing incidence of neurological diseases, an increasing number of clinical trials of BCI solutions, and the rising government initiatives.

Prominent players in brain computer interface market include Advanced Brain Monitoring, Inc. (US), ANT Neuro (Netherlands), Bitbrain (Spain), MindMaze (Switzerland), Cortec GmbH (Germany), Kernel (US), Paradromics (US), BrainCo (US), Blackrock Neurotech (US), g.Tech Medical Engineering GmbH (Austria), Emotiv (US), Neurosky (US), Brain Products GmbH (Germany), CGX (US), Ripple Neuro (US), Neurable (US), InteraXon (US), Open BCI (US), Neurolutions, Inc. (US), BirgerMind (Latvia), Cognixion (US), Artinis Medical Systems (Netherlands), AAVAA Inc. (Canada), Nexstem (India), and Conscious Labs (France).

Scope of the Brain Computer Interface Industry

Report Metric

Details

Market Revenue in 2024

$262 million

Projected Revenue by 2029

$506 million

Revenue Rate

Poised to Grow at a CAGR of 14.1%

Market Driver

Growing need to minimize medication errors

Market Opportunity

Growth opportunities in emerging markets

The study categorizes the Brain computer interface market to forecast revenue and analyze trends in each of the following submarkets:

By Component
  • Hardware
  • Software
By Product Type
  • Non-Invasive Brain Computer Interface
  • Partially Invasive Brain Computer Interface
  • Invasive Brain Computer Interface
By Technology
  • Electroencephalography (EEG)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Magnetoencephalography (MEG)
  • Electrocorticography (ECoG)
  • Functional Near-Infrared Spectroscopy (fNRIs)
By Application
  • Disabilities Restoration/ Rehabilitation
  • Assistive Technologies
  • Other Applications
By End User
  • Hospital & Clinics
  • Rehabilitation Centers
  • Home Care Settings
  • Other End Users
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 BRAIN-COMPUTER INTERFACE MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
                    FIGURE 2 BRAIN-COMPUTER INTERFACE MARKET: REGIONAL SEGMENTATION
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 RECESSION IMPACT: BRAIN-COMPUTER INTERFACE MARKET 
 
2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
          FIGURE 3 RESEARCH APPROACH
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                    FIGURE 5 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
    2.3 MARKET SIZE ESTIMATION METHODOLOGY 
          FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 TOP-DOWN APPROACH
          FIGURE 8 BOTTOM-UP APPROACH
          FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN-COMPUTER INTERFACE MARKET (2024–2029)
          FIGURE 10 CAGR PROJECTIONS
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY 
    2.6 LIMITATIONS 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: BRAIN-COMPUTER INTERFACE MARKET
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 49)
    FIGURE 12 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2024 VS. 2027 (USD MILLION)
    FIGURE 15 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2024 VS. 2027 (USD MILLION)
    FIGURE 16 BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2024 VS. 2027 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF BRAIN-COMPUTER INTERFACE MARKET
 
4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 BRAIN-COMPUTER INTERFACE MARKET OVERVIEW 
          FIGURE 18 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE AND COUNTRY (2023) 
          FIGURE 19 NON-INVASIVE BCI ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.3 BRAIN-COMPUTER INTERFACE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 BRAIN-COMPUTER INTERFACE MARKET, BY REGION 2023−2029 
          FIGURE 21 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 BRAIN-COMPUTER INTERFACE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 
          FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 BRAIN-COMPUTER INTERFACE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing incidence & prevalence of neurological disorders
                    5.2.1.2 Increasing demand for non-invasive & wearable BCI devices
                    5.2.1.3 Rising investment in R&D
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of BCI systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging economies
                                FIGURE 24 GLOBAL HEALTHCARE EXPENDITURE SHARE, 1995 VS 2022
                    5.2.3.2 Growing applications of BCI technology
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of trained medical professionals
                    5.2.4.2 Data security & privacy concerns
    5.3 INDUSTRY TRENDS 
           5.3.1 FOCUS ON NON-INVASIVE BCIS
           5.3.2 INTEGRATION WITH WEARABLE TECHNOLOGY
    5.4 PRICING ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE TREND, BY HARDWARE
                    TABLE 2 AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY HARDWARE
           5.4.2 AVERAGE SELLING PRICE TREND OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE
                    TABLE 3 AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 25 VALUE CHAIN ANALYSIS: BRAIN-COMPUTER INTERFACE MARKET
    5.6 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 BRAIN-COMPUTER INTERFACE MARKET: PORTER’S FIVE FORCES
           5.7.1 BARGAINING POWER OF BUYERS
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 THREAT OF NEW ENTRANTS
           5.7.4 THREAT OF SUBSTITUTES
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    TABLE 5 LIST OF KEY STAKEHOLDERS AND THEIR ROLE
                    TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY COMPONENT
           5.8.2 BUYING CRITERIA
                    FIGURE 27 KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT
                    TABLE 7 KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT
    5.9 REGULATORY LANDSCAPE 
           5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.9.2 REGULATORY ANALYSIS
                    5.9.2.1 North America
                               5.9.2.1.1 US
                                              TABLE 11 US FDA: CLASSIFICATION OF MEDICAL DEVICES
                                              TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.9.2.2 Europe
                    5.9.2.3 Asia Pacific
                               5.9.2.3.1 China
                                              TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                               5.9.2.3.2 India
                                              TABLE 14 INDIA: CLASSIFICATION OF NON-NOTIFIED MEDICAL DEVICES
                    5.9.2.4 Latin America
                               5.9.2.4.1 Brazil
                    5.9.2.5 Middle East & Africa
                               5.9.2.5.1 UAE
    5.10 TECHNOLOGY ANALYSIS 
           5.10.1 KEY TECHNOLOGIES
                    5.10.1.1 Artificial Intelligence (AI) and Machine Learning (ML)
                    5.10.1.2 Signal Processing
           5.10.2 COMPLEMENTARY TECHNOLOGIES
                    5.10.2.1 Neuroimaging
                    5.10.2.2 Wearable Technology
           5.10.3 ADJACENT TECHNOLOGIES
                    5.10.3.1 Robotics & Prosthetics
                    5.10.3.2 Virtual Reality (VR) & Augmented Reality (AR)
    5.11 PATENT ANALYSIS 
           5.11.1 PATENT PUBLICATION TRENDS
           5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE
                     FIGURE 28 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013–2023
                     TABLE 15 NUMBER OF DOCUMENTS FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013–2023
           5.11.3 PATENT APPLICATIONS AND OWNERS
                     FIGURE 29 MAJOR PATENTS FOR BRAIN-COMPUTER INTERFACE (2013–2023)
           5.11.4 LIST OF PATENTS/PATENT APPLICATIONS
                     TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS IN BRIAN COMPUTER INTERFACE MARKET, JANUARY 2021-MAY 2024
    5.12 REIMBURSEMENT SCENARIO ANALYSIS 
    5.13 BUSINESS MODEL ANALYSIS 
    5.14 TRADE ANALYSIS 
           5.14.1 TRADE ANALYSIS FOR BRAIN-COMPUTER INTERFACE MARKET
                     FIGURE 30 IMPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021–2023 (USD THOUSAND)
                     FIGURE 31 EXPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021–2023 (USD THOUSAND)
    5.15 CASE STUDY ANALYSIS 
           TABLE 17 CASE STUDY 1: EXPLORING USER-CENTERED DESIGN PERSPECTIVES IN BRAIN-COMPUTER INTERFACE RESEARCH
           TABLE 18 CASE STUDY 2: ASSESSING THE INTEGRATION OF BRAIN-COMPUTER INTERFACE AND INTERNET OF THINGS FOR HEALTHCARE APPLICATIONS
    5.16 KEY CONFERENCES & EVENTS, 2024–2025 
           TABLE 19 LIST OF KEY CONFERENCES & EVENTS IN BRAIN-COMPUTER INTERFACE MARKET, JANUARY 2024–DECEMBER 2025
    5.17 UNMET NEEDS AND END-USER EXPECTATIONS 
           5.17.1 UNMET NEEDS
                     TABLE 20 UNMET NEEDS IN BRAIN-COMPUTER INTERFACE MARKET
           5.17.2 END-USER EXPECTATIONS
                     TABLE 21 END-USER EXPECTATIONS IN BRAIN-COMPUTER INTERFACE MARKET
    5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.19 INVESTMENT AND FUNDING LANDSCAPE 
          FIGURE 32 FUNDING IN BRAIN-COMPUTER INTERFACE MARKET, BY PLAYER
 
6 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT (Page No. - 90)
    6.1 INTRODUCTION 
          TABLE 22 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
    6.2 HARDWARE 
           6.2.1 ADVANCEMENTS IN HARDWARE AND INCREASING DEMAND FOR NON-INVASIVE BCI SOLUTIONS TO DRIVE MARKET GROWTH
                    TABLE 23 BRAIN-COMPUTER INTERFACE HARDWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 SOFTWARE 
           6.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED BCI SOFTWARE SOLUTIONS TO FUEL MARKET GROWTH
                    TABLE 24 BRAIN-COMPUTER INTERFACE SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE (Page No. - 94)
    7.1 INTRODUCTION 
          TABLE 25 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
    7.2 NON-INVASIVE BRAIN-COMPUTER INTERFACES 
           7.2.1 DEVELOPMENT OF ADVANCED EEG HEADSETS TO DRIVE ADOPTION
                    TABLE 26 NON-INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACES 
           7.3.1 TECHNOLOGICAL ADVANCEMENTS AND RISING NEUROLOGICAL DISORDER INCIDENCE TO DRIVE DEMAND
                    TABLE 27 PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 INVASIVE BRAIN-COMPUTER INTERFACES 
           7.4.1 GROWING R&D AND RISING INVESTMENTS TO FUEL MARKET GROWTH
                    TABLE 28 INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY (Page No. - 100)
    8.1 INTRODUCTION 
          TABLE 29 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
    8.2 ELECTROENCEPHALOGRAPHY 
           8.2.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET GROWTH
                    TABLE 30 EEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 MAGNETOENCEPHALOGRAPHY 
           8.3.1 HIGH COST OF MEG-BASED BCI SOLUTIONS TO LIMIT MARKET GROWTH
                    TABLE 31 MEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 ELECTROCORTICOGRAPHY 
           8.4.1 FOCUS ON ESTABLISHING FEASIBILITY & EFFICACY OF ECOG-BASED BCIS TO DRIVE MARKET
                    TABLE 32 ECOG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.5 FUNCTIONAL MAGNETIC RESONANCE IMAGING 
           8.5.1 LARGE SIZE AND HIGH PRICE OF FMRI SCANNERS TO LIMIT APPLICATIONS IN HOME CARE SETTINGS
                    TABLE 33 FMRI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.6 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY 
           8.6.1 PORTABILITY, SAFETY, AND REAL-TIME BRAIN ACTIVITY MONITORING TO FUEL DEMAND
                    TABLE 34 FNIRS-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.7 DIRECT DATA INTERFACE 
           8.7.1 HIGH COST AND LIMITED REIMBURSEMENT OPTIONS TO RESTRAIN GROWTH
                    TABLE 35 DDI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION (Page No. - 109)
    9.1 INTRODUCTION 
          TABLE 36 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
    9.2 ASSISTIVE TECHNOLOGIES 
           9.2.1 DEVELOPMENT OF INNOVATIVE SOLUTIONS AND GROWING R&D TO BOOST ADOPTION OF BCI IN ASSISTIVE TECHNOLOGIES
                    TABLE 37 BRAIN-COMPUTER INTERFACE MARKET FOR ASSISTIVE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 DISABILITIES & REHABILITATION 
           9.3.1 RISING DEMAND FOR ADVANCED SOLUTIONS AND INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
                    TABLE 38 BRAIN-COMPUTER INTERFACE MARKET FOR DISABILITIES & REHABILITATION, BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 OTHER APPLICATIONS 
          TABLE 39 BRAIN-COMPUTER INTERFACE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
10 BRAIN-COMPUTER INTERFACE MARKET, BY END USER (Page No. - 115)
     10.1 INTRODUCTION 
             TABLE 40 BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.2 HOSPITALS & CLINICS 
             10.2.1 EARLY ADOPTION, WIDE APPLICATIONS, AND GROWING R&D TO SUPPORT MARKET GROWTH
                        TABLE 41 BRAIN-COMPUTER INTERFACE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.3 REHABILITATION CENTERS 
             10.3.1 SHORTAGE OF TRAINED PROFESSIONALS TO CHALLENGE MARKET GROWTH
                        TABLE 42 BRAIN-COMPUTER INTERFACE MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.4 HOME CARE SETTINGS 
             10.4.1 PREFERENCE FOR IN-HOME CARE AND GROWING AGING POPULATION TO DRIVE DEMAND
                        TABLE 43 BRAIN-COMPUTER INTERFACE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
     10.5 OTHER END USERS 
             TABLE 44 BRAIN-COMPUTER INTERFACE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
11 BRAIN-COMPUTER INTERFACE MARKET, BY REGION (Page No. - 123)
     11.1 INTRODUCTION 
             TABLE 45 BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022–2029 (USD MILLION)
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 33 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT
                        TABLE 46 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 47 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 48 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 49 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 50 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 51 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.2 US
                        11.2.2.1 US to dominate North American market
                                      TABLE 52 US: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 53 US: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 54 US: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 55 US: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 56 US: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing adoption and government support to propel market growth
                                      TABLE 57 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 58 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 59 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 60 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 61 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT
                        TABLE 62 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 63 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 64 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 65 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 66 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 67 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Government support and demand for neurorehabilitation solutions to fuel market growth
                                      TABLE 68 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 69 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 70 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 71 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 72 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Rising prevalence of neurological disorders to drive market
                                      TABLE 73 UK: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 74 UK: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 75 UK: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 76 UK: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 77 UK: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Rising geriatric population to increase demand for BCI solutions
                                      TABLE 78 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 79 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 80 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 81 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 82 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Increasing initiatives to propel market growth
                                      TABLE 83 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 84 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 85 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 86 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 87 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Rising R&D and improving health spending to drive market
                                      TABLE 88 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 89 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 90 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 91 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 92 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 93 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 94 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 95 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 96 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 97 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 34 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT
                        TABLE 98 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 99 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 100 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 101 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 102 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 103 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Growing demand for assistive technologies to fuel market growth
                                      TABLE 104 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 105 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 106 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 107 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 108 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Technological innovations to increase demand
                                      TABLE 109 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 110 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 111 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 112 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 113 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Increasing government initiatives to boost demand for BCI
                                      TABLE 114 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 115 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 116 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 117 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 118 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 119 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 120 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 121 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 122 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 123 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 124 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 125 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 126 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 127 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 128 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 129 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.2 BRAZIL
                        11.5.2.1 High cost of BCI solutions to hamper market growth
                                      TABLE 130 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 131 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 132 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 133 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 134 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Initiatives for healthcare infrastructure development to support market growth
                                      TABLE 135 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 136 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 137 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 138 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 139 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 140 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 141 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 142 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 143 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 144 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 145 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 146 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 147 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 148 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 149 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 150 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.6.2 GCC COUNTRIES
                        11.6.2.1 Healthcare infrastructural development to drive demand for BCI solutions
                                      TABLE 151 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 152 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                                      TABLE 153 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                                      TABLE 154 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 155 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
             11.6.3 REST OF MIDDLE EAST & AFRICA
                        TABLE 156 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 157 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
                        TABLE 158 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
                        TABLE 159 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 160 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 184)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET
                        FIGURE 35 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
     12.3 MARKET SHARE ANALYSIS 
             FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET (2023)
             TABLE 161 BRAIN-COMPUTER INTERFACE MARKET: DEGREE OF COMPETITION
     12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.4.1 STARS
             12.4.2 PERVASIVE PLAYERS
             12.4.3 EMERGING LEADERS
             12.4.4 PARTICIPANTS
                        FIGURE 37 BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             12.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        12.4.5.1 Company footprint
                                      FIGURE 38 BRAIN-COMPUTER INTERFACE MARKET: COMPANY FOOTPRINT
                        12.4.5.2 Component footprint
                                      TABLE 162 BRAIN-COMPUTER INTERFACE MARKET: COMPONENT FOOTPRINT
                        12.4.5.3 Product type footprint
                                      TABLE 163 BRAIN-COMPUTER INTERFACE MARKET: PRODUCT TYPE FOOTPRINT
                        12.4.5.4 Technology footprint
                                      TABLE 164 BRAIN-COMPUTER INTERFACE MARKET: TECHNOLOGY FOOTPRINT
                        12.4.5.5 Application footprint
                                      TABLE 165 BRAIN-COMPUTER INTERFACE MARKET: APPLICATION FOOTPRINT
     12.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             12.5.1 PROGRESSIVE COMPANIES
             12.5.2 DYNAMIC COMPANIES
             12.5.3 STARTING BLOCKS
             12.5.4 RESPONSIVE COMPANIES
                        FIGURE 39 BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (SMES/ STARTUPS), 2023
             12.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                        TABLE 166 BRAIN-COMPUTER INTERFACE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
                        TABLE 167 BRAIN-COMPUTER INTERFACE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
     12.6 VALUATION AND FINANCIAL METRICS 
             FIGURE 40 EV/EBITDA OF KEY VENDORS
             FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     12.7 BRAND/PRODUCT COMPARISON 
             FIGURE 42 BRAIN-COMPUTER INTERFACE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 168 BRAIN-COMPUTER INTERFACE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
             12.8.2 DEALS
                        TABLE 169 BRAIN-COMPUTER INTERFACE MARKET: DEALS, JANUARY 2021–MAY 2024
             12.8.3 EXPANSIONS
                        TABLE 170 BRAIN-COMPUTER INTERFACE MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
 
13 COMPANY PROFILES (Page No. - 200)
     13.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             13.1.1 NEUROSKY
                        TABLE 171 NEUROSKY: COMPANY OVERVIEW
                        TABLE 172 NEUROSKY: PRODUCTS OFFERED
             13.1.2 EMOTIV
                        TABLE 173 EMOTIV: COMPANY OVERVIEW
                        TABLE 174 EMOTIV: PRODUCTS OFFERED
             13.1.3 ANT NEURO
                        TABLE 175 ANT NEURO: COMPANY OVERVIEW
                        TABLE 176 ANT NEURO: PRODUCTS OFFERED
                        TABLE 177 ANT NEURO: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021–MAY 2024)
                        TABLE 178 ANT NEURO: EXPANSIONS (JANUARY 2021–MAY 2024)
             13.1.4 G.TEC MEDICAL ENGINEERING GMBH
                        TABLE 179 G.TEC MEDICAL ENGINEERING GMBH: COMPANY OVERVIEW
                        TABLE 180 G.TEC MEDICAL ENGINEERING GMBH: PRODUCTS OFFERED
             13.1.5 NEURABLE
                        TABLE 181 NEURABLE: COMPANY OVERVIEW
                        TABLE 182 NEURABLE: PRODUCTS OFFERED
                        TABLE 183 NEURABLE: DEALS (JANUARY 2021–MAY 2024)
             13.1.6 ADVANCED BRAIN MONITORING, INC.
                        TABLE 184 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW
                        TABLE 185 ADVANCED BRAIN MONITORING, INC.: PRODUCTS OFFERED
             13.1.7 BRAIN PRODUCTS GMBH
                        TABLE 186 BRAIN PRODUCTS GMBH: COMPANY OVERVIEW
                        TABLE 187 BRAIN PRODUCTS GMBH: PRODUCTS OFFERED
             13.1.8 CGX
                        TABLE 188 CGX: COMPANY OVERVIEW
                        TABLE 189 CGX: PRODUCTS OFFERED
                        TABLE 190 CGX: EXPANSIONS (JANUARY 2021–MAY 2024)
             13.1.9 RIPPLE NEURO
                        TABLE 191 RIPPLE NEURO: COMPANY OVERVIEW
                        TABLE 192 RIPPLE NEURO: PRODUCTS OFFERED
             13.1.10 BITBRAIN TECHNOLOGIES
                        TABLE 193 BITBRAIN TECHNOLOGIES: COMPANY OVERVIEW
                        TABLE 194 BITBRAIN TECHNOLOGIES: PRODUCTS OFFERED
             13.1.11 OPEN BCI
                        TABLE 195 OPENBCI: COMPANY OVERVIEW
                        TABLE 196 OPENBCI: PRODUCTS OFFERED
             13.1.12 ARTINIS MEDICAL SYSTEMS
                        TABLE 197 ARTINIS MEDICAL SYSTEMS: COMPANY OVERVIEW
                        TABLE 198 ARTINIS MEDICAL SYSTEMS: PRODUCTS OFFERED
             13.1.13 PARADROMICS
                        TABLE 199 PARADROMICS: COMPANY OVERVIEW
                        TABLE 200 PARADROMICS: PRODUCTS OFFERED
                        TABLE 201 PARADROMICS: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)
             13.1.14 BRAINCO, INC.
                        TABLE 202 BRAINCO, INC.: COMPANY OVERVIEW
                        TABLE 203 BRAINCO, INC.: PRODUCTS OFFERED
             13.1.15 MINDMAZE
                        TABLE 204 MINDMAZE: COMPANY OVERVIEW
                        TABLE 205 MINDMAZE: PRODUCTS OFFERED
                        TABLE 206 MINDMAZE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021–MAY 2024)
                        TABLE 207 MINDMAZE: DEALS (JANUARY 2021–MAY 2024)
             13.1.16 COGNIXION
                        TABLE 208 COGNIXION: COMPANY OVERVIEW
                        TABLE 209 COGNIXION: PRODUCTS OFFERED
                        TABLE 210 COGNIXION: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)
             13.1.17 BLACKROCK NEUROTECH
                        TABLE 211 BLACKROCK NEUROTECH: COMPANY OVERVIEW
                        TABLE 212 BLACKROCK NEUROTECH: PRODUCTS OFFERED
                        TABLE 213 BLACKROCK NEUROTECH: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024)
             13.1.18 CORTEC GMBH
                        TABLE 214 CORTEC GMBH: COMPANY OVERVIEW
                        TABLE 215 CORTEC GMBH: PRODUCTS OFFERED
             13.1.19 INTERAXON, INC.
                        TABLE 216 INTERAXON, INC.: COMPANY OVERVIEW
                        TABLE 217 INTERAXON, INC.: PRODUCTS OFFERED
             13.1.20 NEUROLUTIONS, INC.
                        TABLE 218 NEUROLUTIONS, INC.: COMPANY OVERVIEW
                        TABLE 219 NEUROLUTIONS, INC.: PRODUCTS OFFERED
                        TABLE 220 NEUROLUTIONS: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)
     13.2 OTHER PLAYERS 
             13.2.1 CONSCIOUS LABS
                        TABLE 221 CONSCIOUS LABS: COMPANY OVERVIEW
                        TABLE 222 CONSCIOUS LABS: PRODUCTS OFFERED
             13.2.2 KERNEL
                        TABLE 223 KERNEL: COMPANY OVERVIEW
                        TABLE 224 KERNEL: PRODUCTS OFFERED
                        TABLE 225 KERNEL: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024)
             13.2.3 AAVAA INC.
                        TABLE 226 AAVAA INC.: COMPANY OVERVIEW
                        TABLE 227 AAVAA INC.: PRODUCTS OFFERED
                        TABLE 228 AAVAA: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024)
             13.2.4 NEXSTEM
                        TABLE 229 NEXSTEM: COMPANY OVERVIEW
                        TABLE 230 NEXSTEM: PRODUCTS OFFERED
             13.2.5 BIRGERMIND
                        TABLE 231 BIRGERMIND: COMPANY OVERVIEW
                        TABLE 232 BIRGERMIND: PRODUCTS OFFERED
 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 243)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the medical robots market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the brain computer interface market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain computer interface market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global brain computer interface market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Breakdown of Primary Interviews

Brain Computer Interface Market Size, and Share

Note 1: Tiers are defined based on the total revenues of companies. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global brain computer interface market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • Key players in the global brain computer interface market were identified through secondary research, and their global market shares were determined through primary and secondary research
  • The research methodology included the study of the annual and quarterly financial reports and regulatory filings, data books of major market players, and interviews with industry experts for detailed market insights.
  • All percentage shares, splits, and breakdowns for the global brain computer interface market were determined by using secondary sources and verified through primary sources.
  • All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data.
  • The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report.

Global Brain Computer Interface Market: Bottom-Up Approach

Brain Computer Interface Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Brain Computer Interface Market: Top-Down Approach

Brain Computer Interface Market Size, and Share

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the brain computer interface market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical robots market.

Market Definition:

Brain-computer interface (BCI) refers to a technology that enables direct communication between the human brain and external devices, such as computers or prosthetic limbs, without the need for traditional input methods like keyboards. BCIs typically utilize various methods to capture the electrical activity generated by the brain utilizing different approaches such as electroencephalography (EEG) magnetoencephalography (MEG), functional near-infrared spectroscopy (fNIRS) or invasive neural implants, to interpret a user's intentions or commands. This allows individuals to interact with technology using only their thoughts or brain activity.

The BCI market encompasses the development, manufacturing, and deployment of these BCI systems and related technologies for various applications.

Key Stakeholders:

  • Manufacturers of brain computer interface solutions
  • Suppliers and distributors of brain computer interface solutions
  • Third-party refurbishers/suppliers
  • Clinical settings
  • Educational institutions
  • Group purchasing organizations (GPOs)
  • Academic research centers and universities
  • Corporate entities
  • Rehabilitation centers
  • Market research & consulting firms
  • Contract manufacturing organizations (CMOs)
  • Venture capitalists & investors

Report Objectives

  • To define, describe, and forecast the brain computer interface market by component, product type, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall brain computer interface market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies2
  • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments, such as partnerships, product launches & approvals, and expansions
  • To benchmark players within the brain computer interface market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Additional Company Profiling

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe brain computer interface market into Switzerland, Russia, and others
  • Further breakdown of the Rest of Asia Pacific brain computer interface market into South Korea, Singapore, and others
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
HIT 9020
Published ON
May, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Brain Computer Interface Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback